Additional large-scale studies in well-powered replication cohorts involving neuroimaging, neuropathology, and questions about dietary nutrients are required to understand the underlying mechanisms of the effects of functional SNVs of VC transporter genes on APOE4-associated risk of developing AD. The gene discussed is APOE; the disease is Alzheimer disease.